Jury Hands Down a Verdict in Prevagen Deceptive Marketing Case
Verdict comes nine years after TINA.org alerted regulator to supplement’s unsubstantiated health claims.
In June 2020, a class-action lawsuit was filed against GermBloc and WillSpeed Technology for allegedly misleadingly marketing that GermBloc alcohol-free hand sanitizer kills “99.99% of germs” and prevents diseases when, according to plaintiffs, there is no scientific evidence to support such claims. (Lagorio et al v. GermBloc, Inc. and WillSpeed Technology LLC, Case No. 20-cv-11074, D. Mass.)
For more of TINA.org’s coverage of hand sanitizers, click here.
Verdict comes nine years after TINA.org alerted regulator to supplement’s unsubstantiated health claims.
Regulators have a beef with company’s climate pledge.
Consumers need to be wary of undisclosed incentivized reviews.
Why TINA.org supports FTC’s proposed changes to COPPA Rule but pushes for more.
FTC alleges company pressures consumers into overpaying for its tax filing software.